Skip to main content
Premium Trial:

Request an Annual Quote

GeneFrontier to Make, Market Abcellute's Hepatocyte Tech to Japanese Drug Makers

NEW YORK (GenomeWeb News) — Welsh research company Abcellute today said it has signed an exclusive deal with microarray service provider GeneFrontier to manufacture, market, and distribute Abcellute’s hepatocyte cell-preservation products in Japan.
 
The agreement also gives Tokyo-based GeneFrontier rights to pen sub-license deals with the technology with pharma companies.    
 
Abcellute said its cell-preservation technology allows drug developers to evaluate drugs using hepatocytes that may be kept at non-freezing temperatures throughout a working week.
 
Financial terms of the deal were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more